Evan Greif is a Principal at Bain Capital since August 2020, with a robust background in finance and board governance. Current board roles include Board Observer at Timberlyne Therapeutics and HeartFlow, Inc., and Board Member at CereVasc, alongside a Board Observer role at Serán BioScience. Previously, Evan served as an Analyst at Orbis Investments and as an Associate Consultant at Bain & Company. Educational qualifications include a Master's degree in Statistics from Harvard University and a Master's degree in Mathematics from the University of Cambridge, complemented by a Bachelor of Arts in Applied Mathematics from Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices